Protective effect of allograft inflammatory factor-1 on the apoptosis of fibroblast-like synoviocytes in patients with rheumatic arthritis induced by nitro oxide donor sodium nitroprusside

Scandinavian Journal of Rheumatology

Volumn 42, Issue 5, 2013, Pages 349-355

  Liu, Y ^a   Mei, C ^a   Du, R ^a   Shen, L ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALLOGRAFT INFLAMMATORY FACTOR 1; LY 2940042; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN BAD; PROTEIN KINASE B; PYRROLIDINE DITHIOCARBAMATE; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CELL ASSAY; CELL CULTURE; CELL VIABILITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME PHOSPHORYLATION; FEMALE; FIBROBLAST; FIBROBLAST LIKE SYNOVIOCYTE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; IN VITRO STUDY; MALE; NICK END LABELING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; SURVIVAL RATE; SYNOVIOCYTE; SYNOVIUM; WESTERN BLOTTING;

APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; CHROMONES; DNA-BINDING PROTEINS; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; FIBROBLASTS; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MORPHOLINES; NITRIC OXIDE DONORS; NITROPRUSSIDE; PHOSPHORYLATION; PYRROLIDINES; RHEUMATIC FEVER; SEVERITY OF ILLNESS INDEX; SYNOVIAL MEMBRANE; THIOCARBAMATES;

EID: 84882760756     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2013.772233     Document Type: Article

References (29)

1. Utans U, Quist WC, McManus BM, Wilson JE, Arceci RJ, Wallace AF, et al. Allograft inflammatory factory-1. A cytokine-responsive macrophage molecule expressed in transplanted human hearts. Transplantation 1996;61:1387-92.
2. Del Galdo F, Jimenez SA. T cells expressing allograft inflammatory factor 1 display increased chemotaxis and induce a profibrotic phenotype in normal fibroblasts in vitro. Arthritis Rheum 2007; 56:3478-88.
3. Autieri, MV. cDNA cloning of human allograft inflammatory factor-1: tissue distribution, cytokine induction, and mRNA expression in injured rat carotid arteries. Biochem Biophys Res Commun 1996;228:29-37.
4. Utans U, Arceci RJ, Yamashita Y, Russell ME. Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. J Clin Invest 1995;95:2954-62.
5. Barker AK, McDaniel DO, Zhou X, He Z, Aru G, Thomas T, et al. Combined analysis of allograft inflammatory factor-1, interleukin-18, and Toll-like receptor expression and association with allograft rejection and coronary vasculopathy. Am Surg 2010;76:872-8.
6. Sommerville LJ, Kelemen SE, Ellison SP, England RN, Autieri MV. Increased atherosclerosis and vascular smooth muscle cell activation in AIF-1 transgenic mice fed a high-fat diet. Atherosclerosis 2012;220:45-52.
7. Li T, Feng Z, Jia S, Wang W, Du Z, Chen N, et al. Daintain/AIF-1 promotes breast cancer cell migration by up-regulated TNF-α via activate p38 MAPK signaling pathway. Breast Cancer Res Treat 2012;131:891-8.
8. Huang X, Zhao Y, Jia S, Yan D, Chen Z. Effects of daintain/AIF-1 on β cell dysfunction in INS-1 cells. Biosci Biotechnol Biochem 2011;75:1842-4.
9. Schluesener HJ, Seid K, Meyermann R. Effects of autoantigen and dexamethasone treatment on expression of endothelial-monocyte activating polypeptide II and allograft inflammatory factor-1 by activated macrophages and microglial cells in lesions of experimental autoimmune encephalomyelitis, neuritis, and uveitis. Acta Neuropathol 1999;97:119-26.
10. Yamamoto A, Ashihara E, Nakagawa Y, Obayashi H, Ohta M, Hara H, et al. Allograft inflammatory factor-1 is overexpressed and induces fibroblast chemotaxis in the skin of sclerodermatous GVHD in a murine model. Immunol Lett 2011;135:144-50.
11. Kimura M, Kawahito Y, Obayashi H, Ohta M, Hara H, Adachi T, et al. A critical role for allograft inflammatory factor-1 in the pathogenesis of rheumatoid arthritis. J Immunol 2007;178:3316-22.
12. Xia L, Shen H, Zhao L, Lu J. Elevated levels of interleukin-27 in patients with Sjögren's syndrome. Scand J Rheumatol 2012;41:73-4.
13. Kim WU, Yoo SA, Min SY, Park SH, Koh HS, Song SW, et al. Hydroxychloroquine potentiates Fas-mediated apoptosis of rheumatoid synoviocytes. Clin Exp Immunol 2006;144: 503-11.
14. Nagatani K, Itoh K, Nakajima K, Kuroki H, Katsuragawa Y, Mochizuki M, et al. Rheumatoid arthritis fibroblast-like synoviocytes express BCMA and are stimulated by APRIL. Arthritis Rheum 2007;56:3554-63.
15. Ueki Y, Miyake S, Tominaga Y, Eguchi K. Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 1996;23:230-6.
16. Szalay B, Mészáros G, Cseh Á, Ács L, Deák M, Kovács L, et al. Adaptive immunity in ankylosing spondylitis: phenotype and functional alterations of T-cells before and during infliximab therapy. Clin Dev Immunol 2012;2012:808724.
17. Nagy G, Clark JM, Buzas E, Gorman C, Pasztoi M, Koncz A, et al. Nitric oxide production of T lymphocytes is increased in rheumatoid arthritis. Immunol Lett 2008;118:55-8.
18. Nakamura H, Ueki Y, Sakito S, Matsumoto K, Yano M, Miyake S, et al. Clinical effects of actarit in rheumatoid arthritis: improvement of early disease activity mediated by reduction of serum concentrations of nitric oxide. Clin Exp Rheumatol 2000;18:445-50.
19. Toh ML, Gonzales G, Koenders MI, Tournadre A, Boyle D, Lubberts E, et al. Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression. PLoS One 2010;5:e13416.
20. Chen Q, Casali B, Pattacini L, Boiardi L, Salvarani C. Tumor necrosis factor-alpha protects synovial cells from nitric oxide induced apoptosis through phosphoinositide 3-kinase Akt signal transduction. J Rheumatol 2006;33:1061-8.
21. Yang ZF, Ho DW, Lau CK, Lam CT, Lum CT, Poon RT, et al. Allograft inflammatory factor-1 (AIF-1) is crucial for the survival and pro-inflammatory activity of macrophages. Int Immunol 2005;17:1391-7.
22. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007;129:1261-74.
23. Bours V, Bentires-Alj M, Hellin AC, Viatour P, Robe P, Delhalle S, et al. Nuclear factor-kappa B, cancer, and apoptosis. Biochem Pharmacol 2000;60:1085-9.
24. Meng F, Liu L, Chin PC, D'Mello SR. Akt is a downstream target of NF-kappaB. J Biol Chem 2002;277:29674-80.
25. Tian Y, Kelemen SE, Autieri MV. Inhibition of AIF-1 expression by constitutive siRNA expression reduces macrophage migration, proliferation, and signal transduction initiated by atherogenic stimuli. Am J Physiol Cell Physiol 2006;290:C1083-91.
26. Liu S, Tan WY, Chen QR, Chen XP, Fu K, Zhao YY, et al. Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-kappaB/cyclin D1 pathway and facilitates tumor growth. Cancer Sci 2008;99:952-7.
27. Morel J, Audo R, Hahne M, Combe B. Tumor necrosis factorrelated apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogenactivated protein kinases and phosphatidylinositol 3-kinase/Akt. J Biol Chem 2005;280:15709-18.
28. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002;296:1655-7.
29. Pastorino JG, Tafani M, Farber JL. Tumor necrosis factor induces phosphorylation and translocation of BAD through a phosphatidylinositide-3-OH kinase-dependent pathway. J Biol Chem 1999;274:19411-16.